HOME >> MEDICINE >> NEWS
Actonel helped preserve bone quality at five years, new data show

MINNEAPOLIS (September 22, 2003) Actonel (risedronate sodium tablets) helped preserve important aspects of bone quality at five years in postmenopausal women with osteoporosis, according to new research presented at the 25th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR).

"Studies suggest that bone quality may be an important contributor to bone strength and fracture resistance. These new data provide value in learning how therapies such as risedronate affect bone quality," said principal investigator Eleftherios P. Paschalis, PhD, Ludwig Boltzmann Institute for Osteology, Vienna. "However, additional studies are necessary to fully understand how the different aspects of bone quality relate to fracture risk."

One aspect of bone quality is the integrity of the material components of bone. Bone is a living tissue composed of calcium-based mineral crystals that are embedded in a network of protein fibers, called collagen. In osteoporotic bone, the calcium-based mineral crystals enlarge and the integrity of the collagen deteriorates compared to what is found in normal bone. Actonel, as shown in study biopsies, maintained the size of the calcium crystals and the integrity of the collagen structure over five years of treatment. Actonel is the only osteoporosis therapy for which these aspects of bone quality have been evaluated in bone biopsies taken from the same patients before and after five years of treatment.

About the Study
The study analyzed paired iliac crest biopsies from eight postmenopausal women with osteoporosis who received Actonel (5mg/day) over a 5-year period. The biopsies were analyzed with a novel imaging technique called Fourier Transform Infrared Spectroscopic Imaging (FTIRI), which provides microscopic information on the size of the calcium-based mineral crystals (crystallinity) and the structure of the collagen (collagen cross-link ratio, pyr/deH-DHLNL).

Biopsies
'"/>


22-Sep-2003


Page: 1 2 3 4 5

Related medicine news :

1. Actonel reduced nonveterbral fracture as early as 6 months
2. New analysis shows early intervention with Actonel reduces first vertebral fracture risk
3. FDA approves Actonel for once-a-week use
4. Study shows Actonel reduces vertebral fracture risk 70 percent in patients on chronic steroid therapy
5. Has cricket helped to unite South Asia?
6. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control
7. Media focus on endostatin helped -- not hurt --
8. Burnout patients helped by comparisons with colleagues
9. Investigational transplant drug effectively preserves kidneys while avoiding toxic side effects
10. Doctors transplant ovary to womans arm to preserve fertility
11. Physical activity in later years helps women preserve functional abilities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ... February 20, 2017 , ... Researchers at the University of ... well as a marker that may predict response to a particular class of drugs, ... of cancer as well. The new findings were published in Proceedings of the National ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... Biscom Document Router (BDR), the first IoT device from Biscom designed to deliver ... Biscom will debut BDR at HIMSS17 and will be conducting demonstrations ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... ... 2017 , ... Chuck E. Cheese’s® and Center for Autism and Related Disorders ... E. Cheese’s locations throughout New England, New York and New Jersey to provide children ... fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. , After a ...
(Date:2/19/2017)... ... , ... The Citadel’s new Swain Department of Nursing , along with ... Ph.D. Joseph was engaged by the college as a consultant to help build the ... a nation-wide search, she was selected to head the department as nurse administrator, assuming ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... India , February 20, 2017 According to ... (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), ... 2021" published by MarketsandMarkets, The market is projected to reach USD 52.37 ... of 6.5% during the forecast period. Continue ... ...
(Date:2/20/2017)... 2017   Alberty   Drugs , ... has announced a significant shift in focus ... programs to servicing local Veteran Affairs Centers (VA) and ... an increased need to secure cost effective treatments for ... locally for their goods & services. "The ...
(Date:2/20/2017)... Acute, Chronic and Prophylaxis GVHD The global graft versus ... from 2016-2021 and CAGR of 3% from 2021-2027. The market is expected ... market is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn ... How this report ... the future business opportunities emerging in this sector. In this ...
Breaking Medicine Technology:
Cached News: